Searchable abstracts of presentations at key conferences in endocrinology

ea0028p17 | Bone | SFEBES2012

Audit of pre-operative imaging in primary hyperparathyroidism

McLaren Laura , Gallagher Andrew , Gallacher Stephen , MacLean Fergus , Hinnie John

Introduction: Primary hyperparathyroidism (PHPT) affects 0.3% of the population. It is characterised by hypercalcaemia with an inappropriately high parathyroid hormone level. The majority of patients with primary hyperparathyroidism are asymptomatic and are diagnosed following an incidental finding of hypercalcaemia. Symptomatic disease is related to hypercalcaemia and can present with complications such as renal calculi and osteoporosis. Parathyroidectomy is the treatment of ...

ea0050p055 | Bone and Calcium | SFEBES2017

The incidence of Bisphosphonate related Osteonecrosis of the Jaw (BONJ) in patients treated with oral bisphosphonates for osteoporosis

MacLean Fergus , Mason Rebecca , Downie Jeff , Watt Iain , Gallagher Andrew , Gallacher Stephen , Hinnie John

Introduction: BONJ is a recognised complication of bisphosphonate treatment (both oral and intravenous). Data are sparse with the reported incidence of BONJ in the oral treatment of osteoporosis between 0.01% to 0.067% or alternatively described as 1.04 to 69 per 100,000 patient-years. This study aimed to estimate the incidence of BONJ in patients taking oral bisphosphonates as a treatment for osteoporosis.Methods: Forth Valley Hea...

ea0050p055 | Bone and Calcium | SFEBES2017

The incidence of Bisphosphonate related Osteonecrosis of the Jaw (BONJ) in patients treated with oral bisphosphonates for osteoporosis

MacLean Fergus , Mason Rebecca , Downie Jeff , Watt Iain , Gallagher Andrew , Gallacher Stephen , Hinnie John

Introduction: BONJ is a recognised complication of bisphosphonate treatment (both oral and intravenous). Data are sparse with the reported incidence of BONJ in the oral treatment of osteoporosis between 0.01% to 0.067% or alternatively described as 1.04 to 69 per 100,000 patient-years. This study aimed to estimate the incidence of BONJ in patients taking oral bisphosphonates as a treatment for osteoporosis.Methods: Forth Valley Hea...

ea0031p19 | Bone | SFEBES2013

Comparison of different measures of urinary calcium excretion in primary hyperparathyroidism

Smith Christopher , Gallagher Andrew , Gallacher Stephen , MacLean Fergus , Johnson Paul , Hinnie John

Patients with primary hyperparathyroidism (PHP) should have assessment of urinary calcium excretion as part of routine work up. This helps in the differential diagnosis of PHP in that urine calcium is low in familial benign hypocalciuric hypercalcaemia. Possible measures of calcium excretion include 24 h urine collection, spot sample for urine for urine calcium concentration and calcium/creatinine ratio (UCa/creat), and fractional excretion of calcium (FrExCa=urine calcium&#21...

ea0031p23 | Bone | SFEBES2013

Audit of cost-saving following introduction of investigation protocol for primary hyperparathyroidism

Skelton Adam , Smith Christopher , McLaren Laura , Stobo David , Gallacher Stephen , Gallagher Andrew , MacLean Fergus , Hinnie John

This group has previously audited the effect of a protocol for investigation of primary hyperparathyroidism (PHP); the protocol stating that only patients meeting criteria for parathyroidectomy should have parathyroid imaging carried out. This showed a reduction in the number of radiological investigations (USS, CT, MRI and sestamibi scans) done in patients with primary hyperparathyroidism following introduction of this protocol.The aim of this audit was...